Open AccessIschemia-Modified albumin level in type 2 diabetes mellitus—Preliminary report
Author(s) -
Agnieszka Piwowar,
Maria KnapikKordecka,
Maria Warwas
Publication year - 2008
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2008/784313
Subject(s) - fructosamine , medicine , microangiopathy , glycemic , diabetes mellitus , albumin , dyslipidemia , ischemia modified albumin , endocrinology , type 2 diabetes mellitus , serum albumin , diabetic angiopathy , ischemia , myocardial ischemia
The main goal of the present study was the evaluation of ischemia-modified albumin (IMA) in patients with type 2 diabetes mellitus and estimation of its connection with vascular complications, glycemic control, hypertension, dyslipidemia and obesity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom